Tech Company Financing Transactions
BiO2 Medical Funding Round
Oxford Finance and private investors invested in a $14 million Series D funding round for BiO2 Medical. The financing round was announced on 1/7/2016.
Transaction Overview
Company Name
Announced On
1/7/2016
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$14,000,000
Round
Series D
Investors
Proceeds Purpose
The financing included a $9m Series D funding round from unnamed backers and a $5m venture debt financing from Oxford Finance LLC (This transaction is structured to initially provide $5 million upon closing, with an option for an additional $3m to be provided upon FDA 510(k) clearance of the Angel Catheter). The company intends to use the funds for the US product launch, the expansion of the US and OUS sales force, incremental R&D projects, and general infrastructure development.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4670 Table Mountain Dr.
Golden, CO 80403
USA
Golden, CO 80403
USA
Phone
Website
Email Address
Overview
BiO2 Medical has created the Angel Catheter to protect critically ill patients from acute Pulmonary Embolism (PE). The innovative design incorporates a retrievable Inferior Vena Cava (IVC) filter, permanently attached to a triple lumen central venous catheter.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 1/7/2016: TAO Connect venture capital transaction
Next: 1/7/2016: Petra Pharma venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs